West Pharmaceutical Services (WST) EPS (Basic) (2009 - 2026)

West Pharmaceutical Services has disclosed EPS (Basic) across 18 years of filings, most recently posting $1.93 for Q1 2026.

• EPS (Basic) for Q1 2026 came in at $1.93, up 55.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.52 (up 17.13% YoY), and the FY2025 annual result was $6.83, up 1.19% from the prior year.
• EPS (Basic) came in at $1.93 for Q1 2026 at West Pharmaceutical Services, up from $1.83 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $2.53 in Q2 2022 to a low of $1.24 in Q1 2025.
• The 5-year median for EPS (Basic) is $1.85 (2023), against an average of $1.84.
• Across the five-year window, EPS (Basic) plunged 31.65% in 2022 and soared 55.65% in 2026, its largest moves.
• West Pharmaceutical Services' EPS (Basic) stood at $1.38 in 2022, then surged by 34.06% to $1.85 in 2023, then decreased by 3.24% to $1.79 in 2024, then increased by 2.23% to $1.83 in 2025, then grew by 5.46% to $1.93 in 2026.
• The last three EPS (Basic) figures came in at $1.93 (Q1 2026), $1.83 (Q4 2025), and $1.94 (Q3 2025), per Business Quant data.